Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has provided an update.
Shanghai Pharmaceuticals Holding Co., Ltd. announced a change in its H Share Registrar in Hong Kong, effective from 1 August 2025. This change to Tricor Investor Services Limited is expected to streamline the registration and transfer process for stakeholders, potentially impacting the company’s operational efficiency and investor relations.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is involved in the manufacturing and distribution of pharmaceutical products and services, focusing on the Chinese market.
Average Trading Volume: 6,974,128
Technical Sentiment Signal: Hold
Current Market Cap: HK$65.32B
For detailed information about 2607 stock, go to TipRanks’ Stock Analysis page.